Express Pharma February 2025
India's Foremost Pharma & Biotech Magazine ~ Decoding the M&A Landscape
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mixed reactions from pharma to Union Budget 2025
Appreciate extending full exemption and concessional tariffs to bulk drugs used for selected lifesaving drugs but hope for…
Exemptions, concessional duty on essential medicines to improve drug access: Sudarshan Jain, IPA
Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA) opines that by prioritising drug accessibility, robust…
Some gaps in Union Budget 2025, but positive policy-level clarifications: Anil Matai, OPPI
Anil Matai, Director General, OPPI observes that while some gaps remain, OPPI is committed to facilitating and partnering with the…
The 6th X-CIPLOG reunion event 2025 was held in Mumbai
X-CIPLOG Reunion 2025 and Excellence Awards reflect industry recognition resonating with the government’s padma bhushan honour to…
ACG – Unlock regulatory insights with our on-demand webinar
Looking to take your DPI products to the Asian market? Regulatory challenges needn’t slow you down.
Watch our…
USFDA approves novel non-opioid treatment for moderate to severe acute pain
Vertex Pharmaceuticals’ Journavx is the first drug to be approved in this new class of pain management medicines
Roche Pharma India appoints Rajwinder Mehdwan as country general manager
She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian Subcontinent) region leadership team
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy…
The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData
Beckman Coulter Life Sciences -Enhancing Root-Cause Investigations in Pharmaceutical Water System…
The FDA's 21CFR guidance highlights the importance of corrective and preventative action (CAPA) in addressing deviations that…